title: Acetylcholine-mediated axon-glia signaling in the developing insect olfactory system.
abstract: In the olfactory system of the sphinx moth Manduca sexta, migration of neuropil glial cells is triggered by olfactory receptor axons and depends on intraglial Ca(2+) signaling. It is not known, however, how receptor axons and glial cells communicate and whether Ca(2+) signaling is a consequence of this communication. We studied Ca(2+) increases in glial cells in vivo and in situ, evoked by electrical stimulation of olfactory receptor axons in pupae and by odor stimulation of receptor neurons in adult moths. Axonal activity leads to Ca(2+) increases in neuropil glial cells that are blocked by nicotinic acetylcholine receptor antagonists and can be mimicked by acetylcholine and carbachol application. In addition, Ca(2+) transients were abolished by removal of external Ca(2+) and blockage of voltage-gated Ca(2+) channels. During development, acetylcholine-mediated Ca(2+) signaling could first be elicited at stage 6, the time when neuropil glial cells start to migrate. Glial migration was reduced after injection of nicotinic antagonists into pupae. The results show that Ca(2+) signaling can be induced by acetylcholine release from olfactory receptor axons, which activates nicotinic acetylcholine receptors and leads to voltage-gated Ca(2+) influx. The results further suggest that cholinergic signaling in the olfactory system is required for glial cell migration in Manduca.
authors.affiliation: Abteilung für Allgemeine Zoologie, TU Kaiserslautern, POB 3049, 67653 Kaiserslautern, Germany.
authors.forename: Jan E
authors.initials: JE
authors.lastname: Heil
authors.forename: Lynne A
authors.initials: LA
authors.lastname: Oland
authors.forename: Christian
authors.initials: C
authors.lastname: Lohr
mesh_terms: D000109:Acetylcholine / Q000378:metabolism* / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects / Q000502:physiology / Q000528:radiation effects; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D001369:Axons / Q000378:metabolism*; D001993:Bronchodilator Agents / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D018679:Cholinergic Agonists / Q000494:pharmacology; D004558:Electric Stimulation / Q000379:methods; D008120:Lobeline / Q000494:pharmacology; D018402:Manduca / Q000502:physiology; D009457:Neuroglia / Q000502:physiology*; D009474:Neurons / Q000166:cytology*; D018722:Nicotinic Agonists / Q000494:pharmacology; D009812:Odorants; D009833:Olfactory Pathways / Q000166:cytology* / Q000254:growth & development*; D011422:Propionates / Q000494:pharmacology; D011679:Pupa; D011804:Quinolines / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology
chemical_list: D000779:Anesthetics, Local; D001993:Bronchodilator Agents; D002121:Calcium Channel Blockers; D018679:Cholinergic Agonists; D018722:Nicotinic Agonists; D011422:Propionates; D011804:Quinolines; D013779:Tetrodotoxin; C059141:verlukast; D002217:Carbachol; D008120:Lobeline; D000109:Acetylcholine; D002118:Calcium